Last quarter (Q3 2025), BioNTech SE's total revenue was €1.52B, an increase of 22.02% from the same quarter last year. In Q3, BioNTech SE's net income was €-28.70M. See BioNTech SE’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	€ 2.75B	€ 3.82B	€ 17.31B	€ 18.98B	€ 482.30M
Gross Profit	€ 2.21B	€ 3.22B	€ 14.32B	€ 16.07B	€ 423.00M
Operating Expenses	€ 3.52B	€ 2.53B	€ 1.67B	€ 781.40M	€ 505.40M
Depreciation and Amortization	€ 298.00M	€ 183.40M	€ 123.30M	€ 75.20M	€ 38.70M
EBITDA	€ -367.10M	€ 1.38B	€ 13.10B	€ 15.00B	€ -105.10M
Operating Income	€ -1.31B	€ 690.40M	€ 12.64B	€ 15.28B	€ -82.40M
Other Income/Expenses	€ 636.60M	€ 495.70M	€ 311.40M	€ -237.40M	€ -63.40M
Pretax Income	€ -677.70M	€ 1.19B	€ 12.95B	€ 15.05B	€ -145.80M
Net Income	€ -665.30M	€ 930.30M	€ 9.43B	€ 10.29B	€ 15.20M
Per Share Metrics
Basic EPS	€ -2.77	€ 3.87	€ 38.08	€ 43.87	€ 0.06
Diluted EPS	€ -2.77	€ 3.83	€ 37.09	€ 41.21	€ 0.06
Weighted Average Shares Outstanding	240.40M	240.60M	243.30M	244.00M	235.44M
Weighted Average Shares Outstanding (Diluted)	240.40M	242.70M	249.80M	259.70M	248.53M

Currency in EUR

BioNTech SE Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing